Clinical Trial Update: Study of Glecaprevir/Pibrentasvir to Assess Safety Through Real-World Data

View source ↗

Summary

This clinical trial update indicates AbbVie is studying the safety of the glecaprevir/pibrentasvir combination in real-world data, with recruitment currently on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Epclusa (sofosbuvir/velpatasvir)

Snippet

Sponsor: AbbVie | Conditions: Hepatitis C Virus (HCV) | Status: RECRUITING